Come dive into one of the curiously delightful conversations overheard at National Geographic’s headquarters, as we follow explorers, photographers, and scientists to the edges of our big, weird, beautiful world. Hosted by Peter Gwin and Amy Briggs.
…
continue reading
Content provided by Oncology Data Advisor® and I3 Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology Data Advisor® and I3 Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Acute Myeloid Leukemia (AML) Awareness Day: Evolving Treatment Directions
MP3•Episode home
Manage episode 415704755 series 1163940
Content provided by Oncology Data Advisor® and I3 Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology Data Advisor® and I3 Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In honor of Acute Myeloid Leukemia (AML) Awareness Day, Oncology Data Advisor Editorial Board and Fellows Forum members Tristan Knight, MD, FRCPC, Richa Thakur, MD, and Joseph Kalis, PharmD, BCOP, hosted a live panel discussion covering the evolving treatment landscape for AML, including: • Novel therapies and combinations such as chimeric antigen receptor (CAR) T-cell therapy and isocitrate dehydrogenase (IDH) inhibitors • The role of measurable residual disease (MRD) testing • Considerations for pediatric transplant and cellular therapy • Words of hope for patients undergoing treatment for AML Additionally, they answered live questions from the audience, including: • Do you have any first-line treatment recommendations for patients with a KMT2A mutation? • When do recommend that patients participate in a clinical trial? Take a listen to hear the panelists’ answers to these questions and their perspectives on the ever-changing therapeutic landscape for AML!
…
continue reading
348 episodes
MP3•Episode home
Manage episode 415704755 series 1163940
Content provided by Oncology Data Advisor® and I3 Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology Data Advisor® and I3 Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In honor of Acute Myeloid Leukemia (AML) Awareness Day, Oncology Data Advisor Editorial Board and Fellows Forum members Tristan Knight, MD, FRCPC, Richa Thakur, MD, and Joseph Kalis, PharmD, BCOP, hosted a live panel discussion covering the evolving treatment landscape for AML, including: • Novel therapies and combinations such as chimeric antigen receptor (CAR) T-cell therapy and isocitrate dehydrogenase (IDH) inhibitors • The role of measurable residual disease (MRD) testing • Considerations for pediatric transplant and cellular therapy • Words of hope for patients undergoing treatment for AML Additionally, they answered live questions from the audience, including: • Do you have any first-line treatment recommendations for patients with a KMT2A mutation? • When do recommend that patients participate in a clinical trial? Take a listen to hear the panelists’ answers to these questions and their perspectives on the ever-changing therapeutic landscape for AML!
…
continue reading
348 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.